Science News
about Medications
Find
Press Releases and Science Updates
by Topic
- Creation of New Neurons Critical to Antidepressant Action in Mice
-
August 7, 2003
•
Press Release
Blocking the formation of neurons in the hippocampus blocks the behavioral effects of antidepressants in mice, say researchers funded by the National Institutes of Health (NIH).
- Medication and Psychotherapy Treat Depression in Low-Income Minority Women
-
July 1, 2003
•
Press Release
Treatment with medication or psychotherapy reduced depressive symptoms in women from minority populations, according to research funded by the National Institute of Mental Health (NIMH).
- Lithium Shows Promise Against Alzheimer’s in Mouse Model
-
May 21, 2003
•
Press Release
An enzyme crucial to formation of Alzheimer’s plaques and tangles may hold promise as a target for future medications, suggest studies in mice and cells.
- Brain Shrinkage in ADHD Not Caused by Medications
-
October 8, 2002
•
Press Release
A 10-year study by National Institute of Mental Health (NIMH) scientists has found that brains of children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) are 3-4 percent smaller than those of children who don't have the disorder—and that medication treatment is not the cause.
- Attention Deficit/Hyperactivity Disorders: Are Children Being Overmedicated?
-
September 26, 2002
•
Press Release
ADHD is the most extensively studied mental disorder of children, with several thousands of peer–reviewed papers in the scientific literature devoted to this topic. ADHD—which affects an estimated 3-5 percent or 2 million young school-age children and an unknown number of teenagers and adults—refers to a family of related chronic neurobiological disorders that interfere with an individual’s capacity to regulate activity level, inhibit behavior, and attend to tasks in developmentally appropriate ways.
- NIMH Study Finds Anti-Psychotic Medication Useful in Treating Serious Behavioral Problems among Children with Autism
-
July 31, 2002
•
Press Release
One of a newer class of anti-psychotic medications was successful and well tolerated for the treatment of serious behavioral disturbances associated with autistic disorder in children ages 5 to 17.
- Drug Targets Brain Circuits that Drive Appetite and Body Weight
-
July 25, 2002
•
Press Release
Research conducted in animals has revealed that an appetite suppressant drug, D-–fenfluramine (D–FEN), activates brain pathways that regulate food intake and body weight.
- Placebo, Antidepressant May Lift Depression Via Common Mechanism
-
May 1, 2002
•
Press Release
Whether it’s a widely prescribed medication or a placebo, a successful treatment for depression must trigger a common pattern of brain activity changes, suggests a team of researchers funded by the National Institute of Mental Health.
